The AGAPEPAEPAQPGVY proline-rich peptide (PRP-1) was isolated from neurosecretory granules of the bovine neurohypophysis; it is produced by N. supraopticus and N. paraventricularis. It has been shown that PRP-1 has many potentially beneficial biological effects, including immunoregulatory, hematopoietic, antimicrobial, and antineurodegenerative properties. Here we showed that PRP increased colony-forming cell (CFC) proliferation in rat bone marrow (BM) cells in vivo. In PRP-treated rat BM, the CFU number at day 7 and day 14 was considerably increased in comparison with untreated rat BM and no difference was found at day 21 and day 28. The related peptide [arg 8 ]vasopressin did not reveal CFC proliferation. PRP failed to farther increase CFC proliferation in vitro in BM obtained from PRP-treated or untreated rats. After 3-4 days of human BM stromal cell cultivation in the presence of 2-20 µg/ml PRP the appearance of cells expressing CD15, CD10, CD11a, CD11b, CD3, CD4, and CD16 surface antigens did not differ from the untreated cells. PRP increased the appearance of CD14-positive cells upon 3-4-day incubation with both adult and fetal BM stromal cells. Our results suggest a previously undescribed role for the hypothalamic peptide within neurosecretory hypothalamus-bone marrow humoral axis, because PRP enhances BM colonyforming cell proliferation and stromal cell differentiation.
INTRODUCTION
gest a new class of neuropeptides from neurosecretory granules of neurohypophysis of cattle, which possesses potent immune-modulatory, antibacterial, and neuropro-Hematopoiesis takes place in bone marrow within the stromal microenvironment. The bone marrow stromal tective properties (7, 8) . One of these polypeptides is AGAPEPAEPAQPGVY proline-rich polypeptide (PRP), cells consist from various cells as endothelial cells, reticular cells, adipocytes, smooth muscle cells, osteoblasts, which has been shown as a regulator of thymocyte differentiation in neonatal and fetal thymus of mice in vivo and stromal fibroblasts. Stromal fibroblasts play the most important role in the support of hematopoiesis. Un-and in vitro and an endogenous regulator of neutrophil and monocytes oxidative burst (1, 3) . der the influence of different cytokines and growth factors they differentiate towards several cell lineages.
In this study, we investigate the influence of PRP on colony-forming cell (CFC) proliferation and human BM Given growth or cytokine-like factor's influence on the cell lineage determination can be studied using col-stromal cell differentiation. The studies on identification of BM cells using antibodies against different clusters ony formation assays. As a cytokine-like factor we sug-1062 GALOYAN ET AL.
of differentiation are carryed out. We suggest a new role 1640, containing 2 mM L-glutamine, 100 µg/ml gentamicine, and 3% FCS. Cells were resuspended in DMEM/ for the hypothalamic peptide within the neurosecretory hypothalamus and bone marrow humoral axis. F12 (1:1) medium with 20% FCS, 2 mM L-glutamine, 1% nonessential amino acids mixture, 50 µg/ml gentam-MATERIALS AND METHODS icine, distributed by 500,000/ml of nuclei-containing In Vitro BM CFC Count cells into 75-cm 2 flasks and cultivated at 37°C and 5% CO 2 . Twenty-four hours after plating, cells were incu-Wistar rats were administered IM with 10 µg of PRP bated with 2-20 µg/ml PRP for 2-4 days and then or [arg 8 ]vasopressin per 100 g of animal weight and conwashed with PBS and fixed with 4% solution of paratrol animals with vehicle only. BM and peripheral blood formaldehyde in 0.1 M PBS (pH 7.4) for 20 min. The (PB) were harvested on days 1 and 4 from both control cells were incubated with monoclonal antibodies against and PRP single dose administered rats (N = 3 in each CD14, CD15, CD10, CD11a, CD11b, CD3, CD4, CD16, group). BM was flushed from rat femurs and red blood CD34, CD45, CD90, and CD105, (Abcam) at 4°C for cells were lysed with 0.83% NH 4 Cl in 0.017 M Tris-12 h. Then the culture dishes were washed three times HCl buffer for 5 min. Nucleated cells were washed with with PBS and incubated with Cy2-conjugated goat anticold RPMI-1640 containing 10% fetal calf serum (FCS), mouse IgG for 1 h. After rinsing with PBS the cells 2 mM L-glutamine, 1 mM sodium pyruvate, 100 U of were covered with glycerol and visualized by fluorespenicillin, and 100 µg of streptomycin per ml and total cence microscope (Olympus, CX41). cell count was determined using a hematological analyzer (Celly v 2.20, Hycel Diagnostics). The total CFC Statistical Analysis count was performed using 5 × 10 6 BM nuclear cells that For each experiment, data are presented as mean valwere cultivated in 5 ml RPMI-1640 containing 0.8% ues ± SEM for each experimental group. Differences bemethylcellulose, 10% FCS, 2 mM L-glutamine, 1 mM tween groups were analyzed using the Graph Pad Prism sodium pyruvate, 100 U of penicillin, and 100 µg of v4.01 software. One-way ANOVA, the Tukey-Kramer streptomycin per 1 ml. Cells were seeded into tissue culmultiple comparisons test (for multiple groups), or Stuture flasks coating BM stromal cells monolayer with dent's t-test (for comparisons between two groups) were 0.1-2 µg/ml PRP and incubated for 28 days at 37°C used. A value of p < 0.05 was considered to be signifiwith 5% CO 2 . At days 7, 14, 21, and 28 individual BM cant. cell colonies, containing at least 15-20 cells, were scored (12).
RESULTS AND DISCUSSION Human BM Cell Isolation and Culture
First, we studied the redistribution of mature lymphocytes, monocytes, and granulocytes between BM and PB Mesenchymal stem cells from fetal human BM were isolated from tubular bones of abortive matter at week in PRP-treated rats and in untreated animals. After harvesting PB and BM from PRP-treated and control rats 19-21 of gestation according to the protocol of Colter et al. (2) . Cells at 1-2 × 10 6 in 1 ml of DMEM supple-at days 1 and 4, the hematological analysis was carried out. The results showed that there was no difference in mented with 10% FCS, 2 mM of L-glutamine and antibiotics were used. They were seeded into plastic dishes percentage of the mature lymphocytes, monocytes, and granulocytes in PRP-treated rats in comparison with and cultured in a humidified atmosphere containing 5% CO 2 at 37°C for 24 h. Adherent cells were incubated control animals at day 1. However, at day 4 there was an increase in the number of monocytes and granulo-until the cells reached confluence and the obtained monolayer had been trypsinized and reseeded at a den-cytes (p < 0.05) in PRP-treated rat BM and PB and a decrease of lymphocytes compared to control (p < 0.05). sity of 20-30 cells for 1 cm 2 of culture dish. Insulintransferrin-selenit (5 µg/ml insulin, 5 µg/ml transferrin, In order to test how an increase of mature cell content in PRP-treated rats reflects the proliferation of BM col-and 5 ng/ml sodium selenite), 20 ng/ml basic fibroblast growth factor (PeproTech, Inc.), and 5 µg/ml heparin ony-forming cells, we performed CFC count in the culture of nucleated BM cells obtained from untreated and were added to the culture media. After 10-14 days (at the third cell passage) of culture, the dense small cell PRP-treated rats after 24 h. We observed that in PRPtreated rats the number of CFC in BM cell culture was colonies were harvested and after an additional 15 days of expansional cultivation cells were stained with the significantly (two-to threefold) increased (p < 0.05) in contrast to untreated animals' BM cell culture (Fig. 1A) . antibodies against CD34, CD45, CD90, and CD105. In general, the cells were used in experiments after six pas-Such an increase was observed at day 7 and day 14 of CFC count with no difference found at day 21 and day sages. BM was obtained from adult volunteer's ilium crest after informed consent and was blended to small 28 of BM cell cultivation. The content of stromal cells covered by small nondifferentiated cells increased in 1-mm fragments, washed in Hanks solution and RPMI in vitro at day 7 and day 14, which does not correlate with increase of CFC content in these concentrations. Furthermore, we analyzed how PRP at higher doses can promote the further increase of CFC content in BM cell culture from PRP-treated rats in vitro. Data presented in Figure 2B show that PRP at 1 and 2 µg/ml does not influence colony formation of BM cells either in control or in PRP-treated rats in vitro. These results suggest that PRP stimulates colony-forming cell proliferation in vivo; however, PRP does not affect the number of colony-forming cells in vitro.
Because we observed an influence of PRP on the formation of stromal cells, we studied PRP effects on the differentiation of human BM stromal cells in the subsequent experiments. In 14-30 days of cultivation of both fetal and adult human BM, the groups of fibroblast-like stromal cells appeared on the bottom of the cultural flasks, followed by monolayer appearance. Morphologically the cells in monolayer were heterogeneous, though the fusiform fibroblast-like ones predominated and the viability of monolayer cells was 85-95%. Two main positive markers of mesenchymal stem cells, CD90 and CD105, were found to be expressed. The proportions of cells carrying them were 93% and 60%, respectively. appearance did not differ from the untreated cells. Among all studied surface antigens only CD14 staining of PRP-treated cells for 3 days differed significantly BM culture obtained from PRP-treated animals. The stromal cells and big colonies remain high at day 14, day from that of untreated stromal cells. In adult human BM stromal cells PRP at concentrations of 2 and 10 µg/ml 21, and day 28 in comparison with untreated animals.
Similarly, in BM cell culture, isolated at 4 days after elicited the number of CD14-positive surface stained cells in comparison with the control (Fig. 3) . Similarly, PRP injection, CFC clonogenic test shown that PRP significantly (p < 0.01) enhances colony formation in BM when fetal human BM stromal cells were kept in medium with 10 µg/ml PRP for 4 days a stronger CD14 (Fig. 1B) . PRP and vasopressin are closely related peptides and produced by the same neurosecretory nuclei of immunostaining of these cells was observed than those of control cells (Fig. 4) . the hypothalamus. We were using [arg 8 ]vasopressin to address the specificity of in vivo BM CFC proliferation BM appears to contain three stem cell populations: hematopoietic stem cells (HSC), stromal cells, and pos-described above. Administration of rats with [arg 8 ]vasopressin did not induce BM CFC proliferation at day 4 sibly endothelial progenitor cells. BM stromal cells (a mixed population that generates bone, cartilage, fat, fi- (Fig. 1B) , indicating specificity of PRP for the enhance colony formation in BM.
brous connective tissue, and reticular network that supports blood cell formation) were described shortly after Next, we analyzed how PRP is able to stimulate directly an increase of CFC count in vitro in BM cell cul-the discovery of hematopoietic stem cells (5, 6) . BM stromal cells have many features that distinguish them tures. BM nuclear cells from untreated rats were isolated and CFC count in the presence of 0.1-2 µg/ml of PRP from HSCs. BM stromal cells form colonies from a single cell called the colony forming unit-F (CFU-F), was performed. We found that PRP in vitro in concentration range of 0.5-2 µg/ml does not influence CFC which is a clonal assay indicating a stem cell-like nature of stromal cells. These colonies may further differentiate count in BM cell culture obtained from untreated rats ( Fig. 2A) . However, we observed that PRP at higher into adipocytes or intramyelosupportive stroma. The scanning electron microscope images show the complex concentrations caused an increase of stromal cell content morphology of stromal cells ("reticular" morphology (26.1%) compared with marrow (2.5%), because equal numbers of CD14 + cells sorted from marrow and G-was the only key for identification of the main cell type in the marrow stroma). The prehematopoietic marrow PBMCs showed comparable ability to induce IL-6 and G-CSF when placed directly on stromal cells (11) . Vir-stroma is formed by "reticular" cells noted for their branched morphology and active DNA synthesis (13).
tually all CD14 + cells present in the BM were found to be CD14 + CD34 low double-positive cells. Endothelial BM stromal cells produce nerve growth factor and glial cell line-derived neurotrophic factors, and these attract progenitor cells as well as purified circulating CD14 + CD34 low cells exhibited high expression of embryonic an interest through their possible use for cell therapy in neurological diseases (15) . stem cell markers. Moreover, circulating CD14 + CD34 low cells, but not CD14 + CD34 − cells, proliferated in response Stromal cells influence the differentiation of hematopoietic stem cells by providing a hematopoietic-inducing to stem cell growth factors, and exhibited clonogenicity and multipotency, as shown by their ability to differenti-microenvironment consisting of a cellular matrix and either membrane-bound or diffusible growth factors.
ate not only into endothelial cells, but also into osteoblasts, adipocytes, or neural cells (14) . Steady-state regulation of hematopoiesis is accomplished in various ways, which include: control of levels Here we have shown that the PRP is able to stimulate CFC proliferation in vivo but not in vitro. In addition, and types of cytokines produced by bone marrow stromal cells; production of cytokines with hematopoietic PRP is able to stimulate stromal BM cell differentiation in hematopoietic direction due to enhancement of CD14 activity by other cell types such as activated T cells and macrophages; regulation of receptor expression for he-surface expression on stromal cells. Thus, the genesis of other cells of hematopoietic line (neutrophils, etc.) in the matopoietically active cytokines in stem and progenitor cells; removal of some cells by the controlled induction stromal cells under the effect of the PRP does not take place. Using markers of hematopoietic cells such as of cell death. Murine BM macrophages efficiently phagocytose apoptotic cells using multiple receptors that in-CD15 (neutrophils), CD3 (T cells), CD16 (NK killers), and CD34 (cells of hematopoietic line) of stromal stem clude CD14, integrins, scavenger receptor, and CD31 (16) . The two growth factor combination of IL-3 and cells, only monocyte (CD14-positive cells) differentiation was observed. When comparing the obtained data stem cell factor stimulated expression of CD14, CD15, platelet glycoprotein IIb/IIIa in suspension culture sys-of earlier studies of the PRP effect on hematopoiesis at lymphocytopenia induced by cyclophosphomide (9), it tem for human hematopoietic progenitor cells (4). Experiments using sorted populations of CD20 + , CD3 + , and seems that at stromal stem cell cultivation PRP stimulates the genesis of monocytes or promonocytes only. CD14 + cells showed that CD14 + cells within granulocyte colony-stimulating factor (G-CSF)-mobilized peripheral
The results of the present experiments confirm Galoyan's conception of the neurosecretory hypothalamus-blood mononuclear cells (G-PBMCs) were responsible for triggering the production of IL-6 and G-CSF. The BM humoral axis existence (8) . In further studies, it will be interesting to determine how PRP influences colony-effect did not require cell-cell contact and was inhibited when neutralizing antibodies to IL-1α and IL-1β were forming cell proliferation in BM for each cell population (lymphocytes, monocytes, granulocytes). Immunohisto-used in combination. In these experiments, the greater stimulating ability of G-PBMCs is most likely attribut-chemically by polyclonal antibodies the localization of PRP in granulocytes of BM had been shown (10) . The able to the greater number of CD14 + cells in G-PBMCs accumulation of a substantial amount of PRP-positive granules in granulocytes as well as an effect of PRP on stromal stem cells indicated the role of PRP in the regulation of lympho-and myelopoiesis.
